Clinical Trials in Arizona

Showing 5921-5940 of 12,706 trials

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

NCT03634982

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-4630 monotherapy in adult participants with relapsed/refractory solid tumors and to identify the recommended Phase 2 dose (RP2D).

Solid Tumors

Revolution Medicines, Inc.133 participantsStarted Sep 2018

Scottsdale, Arizona, United States • Duarte, California, United States • Orange, California, United States +9 more locations

COMPLETEDPhase 135 miles

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

NCT02542969

The purpose of this study is to determine whether MGL-3196 alters the pharmacokinetics of rosuvastatin and/or simvastatin in healthy male subjects and female subjects not of child-bearing potential.

Healthy

Madrigal Pharmaceuticals, Inc.25 participantsStarted Sep 2015

Tempe, Arizona, United States

COMPLETED38 miles

3T MRI CIED Post-Approval Study

NCT02969395

The purpose of this study is to evaluate product performance of Magnetic Resonance (MR) Conditional Cardiac Implantable Electronic Devices (CIED) following 3 tesla (3T) MRI exposure. This will be achieved by evaluating the changes in pacing capture threshold (PCT) measurements following 3T MRI scan exposure. This study is required by FDA as a condition of approval of 3T MRI compatible labeling of applicable CIED systems. This study is conducted within Medtronic's post-market surveillance platform, the Product Surveillance Registry (PSR).

Cardiac Rhythm Disorder

Medtronic41 participantsStarted Apr 2016

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Chandler, Arizona, United States +201 more locations

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin

3T MRI CIED Post-Approval Study

Find Trials by Condition in Arizona

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

A RCT of CenteringPregnancy on Birth Outcomes

Subject Satisfaction With AbobutulinumtoxinA Treatment

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring